The Trump administration has hinted it could be looking into imposing tariffs on pharmaceuticals imported into the country.

Pharmac has since claimed the impact of these tariffs is 'unclear' - as it's unknown how it would affect the price of medicines at this stage.

Medicines NZ chief executive Dr Graeme Jarvis says it's too early to tell, and he doesn't want anyone to react too rashly.

"Around 20 percent of pharmaceutical manufacture is done in the US, the rest of it they import from global supply chains around the world at the moment."

LISTEN ABOVE